Davey, P <br/><br/>
Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Jan 1999 
 - 105-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0305-7453 
<br/><br/><label>Standard No.: </label>10.1093/jac/43.1.105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Anti-Bacterial Agents--administration & dosage<br/>Belgium<br/>Cost-Benefit Analysis<br/>Female<br/>France<br/>Health Care Costs<br/>Humans<br/>Length of Stay--economics<br/>Male<br/>Mass Screening--economics<br/>Middle Aged<br/>Mupirocin--administration & dosage<br/>Peritoneal Dialysis<br/>Staphylococcal Infections--drug therapy<br/>Staphylococcus aureus--drug effects<br/>United Kingdom